V504

HPV vaccine candidate · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for V504, covering 2015-06-08 to 2015-06-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Tolerability and Immunogenicity of V504 Administered Concomitantly With GARDASIL (V504-001)(COMPLETED) [Phase 2]

See pricing